About MGI Pharma
MGI Pharma is a company based in Woodcliff Lake (United States) founded in 1979 was acquired by Eisai in December 2007. MGI Pharma has completed 3 acquisitions, including Aesgen, Guildford Pharmaceuticals and Zycos.
- Headquarter Woodcliff Lake, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MGI Pharma
Investors in MGI Pharma
MGI Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Eisai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drugs for oncology and neurological disorders are developed by Eisai.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MGI Pharma
MGI Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aesgen, Guildford Pharmaceuticals and Zycos.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Limited information available
|
1999 | ||||
|
A US-based specialty pharmaceutical company developing small molecule therapeutics for cancer and neurology.
|
1996 | ||||
|
Limited information available
|
1994 |
Financial Statements - MGI Pharma
Mgi Pharma Comparisons
Competitors of MGI Pharma
Latest news on Mgi Pharma
Frequently Asked Questions about MGI Pharma
MGI Pharma was founded in 1979.
MGI Pharma is headquartered in Woodcliff Lake, United States. It is registered at Woodcliff Lake, New Jersey, United States.
The company was founded in 1979 in Woodcliff Lake, United States, and focused on the pharmaceutical sector, particularly oncology and acute care applications. Pharmaceutical products were developed and commercialized, including Aloxi injection, Dacogen for injection, and Gliadel Wafer. Operations were conducted under the name Molecular Genetics Inc. until 1990, when it became MGI Pharma. Acquisition by Eisai Holdings US subsidiary occurred in 2008.
MGI Pharma has made 3 acquisitions, including Aesgen, Guildford Pharmaceuticals, and Zycos.
MGI Pharma has 1 investor. Key investors include Eisai.